Institutul Oncologic „Prof. Dr. Ion Chiricuţă

What Institutul Oncologic „Prof. Dr. Ion Chiricuţă does

Institutul Oncologic „Prof. Dr. Ion Chiricuță" Cluj-Napoca (IOCN) is a Romanian public medical institution founded in 1929 by Prof. Dr. Iuliu Moldovan, operating as the country's only OECI-designated European Cancer Center. The institute provides comprehensive cancer care across inpatient (522 continuous and 53 day-hospitalization beds), outpatient ambulatory, diagnostic imaging (CT, MRI, scintigraphy, angiography), nuclear medicine, three radiotherapy sections, surgical oncology (I and II), medical oncology, pediatric oncology, hematology, intensive care, and palliative care. It operates three specialized research laboratories (Genetics/Genomics/Experimental Pathology, Radiobiology/Tumor Biology, Anatomic Pathology) and a Biobank, and feeds Romania's cancer registry data into the European Network of Cancer Registries and the European Cancer Information System.

IOCN's business model combines CNAS (Romanian national health insurance) reimbursement for insured patients, fee-for-service tariffs for uninsured patients, EU/PNRR/Norwegian grant funding for infrastructure and programme operations, and medical education revenue through its teaching affiliation with UMF „Iuliu Hațieganu" Cluj-Napoca. Its core go-to-market is direct-access public healthcare delivery plus multi-channel patient outreach through screening mobilization campaigns, an online appointment portal (programari.iocn.ro), mobile screening units, and consortium-led regional partnerships across all Romanian development regions.

The institution's strategic position is anchored by OECI and ASCO accreditations, a near-century of brand equity, and leadership of multiple concurrent EU-funded projects with combined budgets exceeding €500M RON, including the National Cancer Competence Center (CNCC, RON 22.8M), DARIA national breast screening (RON 259.6M), CLARA national cervical screening (RON 258.4M), EUCanScreen Joint Action (€38.7M), CancerWatch JA (€16.2M), and infrastructure modernization (RON 104M). Leadership is provided by Prof. Univ. Dr. Patriciu Achimaș-Cadariu, who coordinates the CNCC consortium.

Name

Institutul Oncologic „Prof. Dr. Ion Chiricuţă

Legal name

Institutul Oncologic "Prof. Dr. Ion Chiricuță"

Website

https://iocn.ro

Company type

Private

Founded year

1929

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Institutul Oncologic „Prof. Dr. Ion Chiricuță" Cluj-Napoca is a Romanian public medical institution and the country's only OECI-designated European Cancer Center, providing comprehensive oncology diagnosis, treatment, research, and screening services to patients across all Romanian development regions since 1929.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology medical services
• Cancer treatment services
• Cancer screening programs
• Radiotherapy services
• Clinical cancer research

Headquarters

HQ city

Cluj-napoca

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. National Health Insurance Revenue: As a public medical institution, IOCN's primary revenue comes from Romania's national health insurance system (CNAS). Services are provided under the social health insurance framework, with reimbursement for insured patients. Emergency services are also provided to uninsured patients.
2. Out-of-Pocket / Fee-for-Service: Fee-based services for uninsured patients and services not covered by national insurance. Administrative and medico-administrative fees are charged per published tariff schedule.
3. EU/International Project Grants: IOCN serves as lead beneficiary or partner on multiple EU-funded projects (EU4Health, POCU, PNRR, Norwegian Funds, EEA Grants). These grants fund infrastructure modernization, screening programs, research capacity building, and digital transformation — not revenue per se but essential funding for operations and investment.
4. Education and Training Services: Continuous medical education, postgraduate training, and professional development programs under the university's teaching mission (affiliated with UMF Iuliu Hațieganu Cluj-Napoca).

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

IOCN is a public oncology hospital and research institute that delivers comprehensive cancer prevention, diagnosis, treatment (surgery, medical oncology, radiotherapy, pediatric oncology, hematology), palliative care, clinical research, and population-level cancer screening for Romania. It operates as a national reference center with 522 inpatient beds and 53 day-hospitalization beds, coordinates major EU-funded screening and research projects, and trains medical professionals in partnership with UMF „Iuliu Haţieganu" Cluj-Napoca.

Product overview

IOCN is a comprehensive oncology medical institution, not a software technology company. It operates as a unified medical facility providing cancer prevention, diagnosis, treatment, and research services. The institution offers a portfolio of interconnected healthcare services including: oncology medical services across multiple specialties (medical oncology, surgical oncology I and II, radiotherapy I-III, pediatric oncology, hematology, and intensive care); organized cancer screening programs for breast, cervical, and colorectal cancers with mobile units and regional centers; advanced diagnostic imaging services (CT, MRI, scintigraphy, angiography); clinical and translational research through specialized laboratories; and medical education programs. The institution also operates the Centrul Național de Competență în Domeniul Cancerului (CNCC), a national cancer competence center developing AI-enabled personalized medicine programs and molecular tumor boards.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• First cancer center in Romania designated as European Cancer Center by OECI (November 2017)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

37 partnerships are on record, tiered core, supporting and minor.

• Institutul Național de Sănătate PublicăcoreStrategic or Co-development Partner · 29 December 2025National public health institute collaborating on the DARIA project as part of IOCN's national breast cancer screening program. Provides epidemiological expertise, public health infrastructure, and national coordination for screening program implementation.
• Spitalul Clinic Municipal de Urgență TimișoaracoreStrategic or Co-development Partner · 29 December 2025Regional partner in the DARIA national breast cancer screening program. Serves as a key screening and treatment hub in the Vest development region of Romania, extending IOCN's national screening program reach.
• Institutul Regional de Oncologie IașicoreStrategic or Co-development Partner · 29 December 2025Regional oncology partner in the DARIA project serving the Nord-Est region. Provides screening, diagnostic, and treatment capacity as part of the national screening consortium.
• Spitalul Clinic Județean de Urgență Târgu MureșsupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the DARIA national screening program. Provides screening infrastructure and clinical capacity in the Centru development region.
• Spitalul Clinic Județean de Urgență CraiovasupportingStrategic or Co-development Partner · 29 December 2025Regional screening partner in the DARIA program covering the Sud-Vest Oltenia region.
• Spitalul Județean de Urgență „Dr. Constantin Andreoiu" PloieștiminorStrategic or Co-development Partner · 29 December 2025Regional partner in the DARIA national breast cancer screening program for the Sud-Muntenia region.
• Spitalul Clinic Județean de Urgență „Sfântul Apostol Andrei" ConstanțasupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the DARIA program covering the Sud-Est development region (Dobrogea).
• Federația Asociațiilor Bolnavilor de CancersupportingStrategic or Co-development Partner · 29 December 2025National cancer patient advocacy federation as a partner in the DARIA screening program. Provides patient mobilization, community outreach, and psychosocial support integration for screening beneficiaries.
• Fundația „Renașterea Pentru Educație, Sănătate și Cultură"supportingStrategic or Co-development Partner · 29 December 2025Patient-facing foundation as partner in the DARIA national screening program. Contributes community education, cultural outreach, and patient support capabilities.
• Institutul Național de Sănătate PublicăcoreStrategic or Co-development Partner · 29 December 2025National public health institute partnering on the CLARA cervical cancer screening project. Provides epidemiological oversight, methodology development, and national coordination for the cervical cancer screening program.
• Spitalul Clinic Județean de Urgență CraiovasupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Sud-Vest Oltenia development region.
• Spitalul Clinic Municipal de Urgență TimișoarasupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Vest development region.
• Spitalul Clinic Județean de Urgență Târgu MureșsupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Centru development region.
• Institutul Regional de Oncologie IașisupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Nord-Est development region.
• Spitalul Clinic Județean de Urgență „Sfântul Apostol Andrei" ConstanțasupportingStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Sud-Est development region.
• Spitalul Județean de Urgență PiteștiminorStrategic or Co-development Partner · 29 December 2025Regional partner in the CLARA cervical cancer screening program for the Sud-Muntenia development region.
• Asociația Centrul de Resurse și Formare în Profesiuni Sociale „Pro Vocație"minorStrategic or Co-development Partner · 29 December 2025Social work professional association partnering on the CLARA project to support community outreach, patient mobilization, and social mediation services for vulnerable screening target groups.
• Asociația COPAČ–RO (Coaliția Organizațiilor Pacienților cu Afecțiuni Cronice din România)supportingStrategic or Co-development Partner · 29 December 2025Chronic disease patient coalition partnering on the CLARA cervical cancer screening program to provide patient advocacy, community engagement, and mobilization of vulnerable target groups.
• Folkehelseinstituttet — National Institute of Public Health (Norway)coreStrategic or Co-development Partner · 1 September 2025Coordinator of the CancerWatch JA (€16.2M total budget). IOCN is the competent authority for Romania with support from the National Institute of Public Health. IOCN is involved in all seven work packages, aiming to improve quality and timeliness of cancer registry data feeding into the European Cancer Information System (ECIS).
• 81 partner organizations from 23 European countries (EU4Health eCAN Plus joint action)coreStrategic or Co-development Partner · 1 May 2025IOCN participates in the flagship eCAN Plus joint action (€4+ year, EU4Health Programme, Grant N° 101219434) focused on digital oncology and cross-border health data exchange. The project tests safe integration of digital tools and health data to improve prevention and care across 23 countries.
• European Institute for Biomedical Imaging Research (EIBIR)coreStrategic or Co-development Partner · 1 September 2024EIBIR is the project coordinator for the CLAUD-IT joint action. IOCN participates as a Romanian competent authority, piloting clinical audits in radiology and nuclear medicine across 9 EU member states. The project runs from 1 September 2024 to 31 August 2027 with €981K total grant.
• University of Latvia (coordinator) and 28 competent authorities + 61 affiliated + 7 associated partners from 29 countriescoreStrategic or Co-development Partner · 1 June 2024IOCN leads Work Package 11 (Capacity building) in the €38.7M EUCanScreen joint action. IOCN coordinates all seven tasks, provides technical and scientific support, and will host a 3-day specialist training course on cervical cancer screening for AIS/pregnancy/immunosuppressed women. Total duration: 48 months.
• Cyprus University of Technology (CUT) — project coordinator + 24 other partners from 14 EU member statescoreStrategic or Co-development Partner · 1 March 2023IOCN leads Work Package 5 (WP5) in the TRANSiTION project — a 24-month EU4Health initiative (March 2023–March 2025) developing an advanced digital skills education program for healthcare professionals. IOCN assesses cancer center needs, establishes eligibility criteria, and oversees trainer selection for clinical and non-clinical professional training.
• Universitatea de Medicină și Farmacie „Carol Davila" BucureșticoreStrategic or Co-development Partner · 30 December 2022Partnership 1 in the CNCC (National Cancer Competence Center) project, coordinated by IOCN and funded through PNRR. UMFCD contributes to the development of personalized medicine programs, digital pathology, and AI-enabled diagnostics within the national cancer research network. Duration: 30.12.2022–30.12.2025.
• Universitatea Politehnică din BucureșticoreTechnology or Integration · 30 December 2022Partnership 2 in the CNCC project. Contributes technical expertise in AI systems, digital imaging infrastructure, and data platform development for the national cancer research network. Part of the PNRR-funded National Cancer Competence Center initiative.
• Institutul Național de Cercetare-Dezvoltare „Victor Babeș" BucureșticoreStrategic or Co-development Partner · 30 December 2022Partnership 4 in the CNCC project. Contributes biomedical research capabilities to the national cancer research network under the PNRR National Cancer Competence Center initiative.
• Universitatea de Medicină și Farmacie „Grigore T. Popa" IașicoreStrategic or Co-development Partner · 30 December 2022Partnership 3 in the CNCC project from the North-East development region. Contributes regional oncology expertise and research capacity to the national cancer competence center network.
• Oncohelp TM SRLsupportingTechnology or Integration · 30 December 2022Partnership 7 in the CNCC project. A private oncology services provider contributing specialized medical expertise and digital health capabilities to the consortium's advanced cancer care programs.
• SC ONCOMED SRLsupportingTechnology or Integration · 30 December 2022Partnership 8 in the CNCC project. A private oncology services company contributing clinical and digital expertise to the national cancer research network's technology integration efforts.
• Centrul de Oncologie Sfânta Nectarie SRLsupportingTechnology or Integration · 30 December 2022Partnership 5 in the CNCC project. A private oncology center contributing specialized treatment capabilities and digital integration to the national cancer competence center network.
• SC Med Life SAsupportingTechnology or Integration · 30 December 2022Partnership 10 in the CNCC project. One of Romania's largest private healthcare networks contributing clinical infrastructure, data management experience, and healthcare technology integration to the consortium.
• Direcția de Sănătate Publică Bistrița-Năsăud (DSP BN)coreStrategic or Co-development Partner · 2 December 2020Regional partner in the cervical cancer screening program for the North-West development region. DSP BN contributes public health authority, community outreach, and screening program implementation in Bistrița-Năsăud county. Total project value: Lei 50,708,577.82.
• Spitalul Clinic Municipal de Urgență TimișoaracoreStrategic or Co-development Partner · 28 August 2020Partener I in the 'Be responsible for your health' regional breast cancer screening program covering Nord-Vest and Vest development regions. IOCN is the partnership leader. Value: Lei 38,255,781.03 total project value.
• Spitalul Clinic de Urgență pentru Copii „Louis Țurcanu" TimișoarasupportingStrategic or Co-development Partner · 24 July 2019Pediatric hospital partner in the Norwegian Grant-funded pediatric oncology capacity building project. IOCN leads with IRO Iași, Institutul Oncologic București, and Norwegian Directorate of Health to improve equipment, training, and guidelines for pediatric cancer diagnosis and treatment.
• Institutul Regional de Oncologie IașisupportingStrategic or Co-development Partner · 24 July 2019Regional partner in the Norwegian Grants pediatric oncology capacity building project, contributing to improved pediatric cancer diagnostic and treatment capabilities across Romania.
• Institutul Oncologic „Prof. Dr. Al. Trestioreanu" BucureștisupportingStrategic or Co-development Partner · 24 July 2019National partner in the Norwegian Grants pediatric oncology project, collaborating on equipment procurement, staff training, and guideline development for pediatric cancer care.
• Universitatea de Medicină și Farmacie „Iuliu Hațieganu" Cluj-NapocacoreStrategic or Co-development PartnerIOCN serves as the primary clinical teaching base for medical students, residents, and fellows of UMF Cluj-Napoca. The partnership encompasses undergraduate medical education, postgraduate specialty training, continuous medical education, and joint research programs. This is a foundational institutional relationship supporting IOCN's academic mission.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Institutul Regional de Oncologie Iași (IRO Iași): Regional oncology institute in Iași providing surgery, radiotherapy, and chemotherapy in the North-East development region. Direct peer collaborating with IOCN on the DARIA and CLARA national screening programs and Norwegian Grants pediatric oncology initiative.
• Institutul Oncologic "Prof. Dr. Al. Trestioreanu" București: Romania's principal oncology institute in Bucharest, providing comprehensive cancer care (surgery, radiotherapy, medical oncology) and a current CNCC partner of IOCN. Most direct functional peer — national counterpart competing for tertiary referrals across Romania.

Regional players

• National Cancer Institute (Slovakia): Slovakia's national comprehensive cancer center in Bratislava. Comparable Central European public cancer hospital with inpatient, outpatient, and research functions and a similar role in national screening coordination.
• Masaryk Memorial Cancer Institute (MOÚ): Czech Republic's comprehensive cancer center combining clinical care, translational research, and university teaching. Comparable Central European public-sector oncology institution with similar mission structure and EU grant profile.
• Maria Skłodowska-Curie National Research Institute of Oncology (Poland): Poland's flagship state-owned cancer research and treatment institute operating multiple regional branches. Comparable Central European public cancer center with similar scale of inpatient beds, research labs, and national screening coordination role.

Broad incumbents

• European Institute of Oncology (IEO): Milan-based comprehensive cancer center with strong surgical oncology, medical oncology, and translational research programs. Comparable European comprehensive cancer center against which IOCN's CNCC personalized medicine ambitions can be benchmarked.
• Netherlands Cancer Institute (NKI): Dutch comprehensive cancer center integrating clinical care and research under one roof. Comparable academic oncology model combining multidisciplinary tumor boards, research labs, and biobank infrastructure similar to IOCN's CNCC aspirations.
• Vall d'Hebron Institute of Oncology (VHIO): Spanish translational oncology research center embedded within the Vall d'Hebron University Hospital. Comparable academic model pairing public hospital oncology with dedicated research infrastructure and international collaborations.
• Gustave Roussy: Europe's largest comprehensive cancer center, OECI-designated, located in the Paris region. Provides a benchmark for OECI Cancer Center operational scale and quality framework that IOCN's designation is built upon.

Others

• MedLife: Romania's largest private healthcare network, and a CNCC consortium partner of IOCN. Functions as both a complementary private provider and an emerging competitor for insured and self-pay oncology patients outside IOCN's public referral base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCqiZraZaOHMj-SoW0lEHCvA
• Facebookfacebook.com/iocncluj
• LinkedInlinkedin.com/company/institutul-oncologic-%E2%80%9Eprof-dr-ion-chiricu%C8%9B%C4%83%E2%80%9D-cluj-napoca
• Instagraminstagram.com/iocn_cluj

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institutul Oncologic „Prof. Dr. Ion Chiricuţă